semaglutide approved for cardiovascular Updates in Medicine | Not just weight loss anymore — is now part of risk reduction. 🫀 Semaglutide protects heart beyond weight

es una estrategia esencial para combatir la epidemia de obesidad

"When patients quit early, as most patients do, that money was wasted

Stirrett Show, the

[76] found no evidence of increased risk of suicidal ideation and self-injury associated with GLP-1 RAs compared to SGLT-2 inhibitors in individuals with T2DM and obesity, based on data from the Valencia Health System Integrated Database (VID) (per-protocol analysis: HR, 1.04

Since gaining weight raises the risk of serious health problems, there is a strong interest in creating medications to help treat obesity

L-Acetylcarnitine causes analgesia in mice modeling Fabry disease by up-regulating type-2 metabotropic glutamate receptors